Acura Pharmaceuticals Cash Flow from Financial Activities 2010-2021 | ACUR
Acura Pharmaceuticals cash flow from financial activities from 2010 to 2021. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
Acura Pharmaceuticals Annual Cash Flow Financial
(Millions of US $) |
| 2021 |
$0 |
| 2020 |
$0 |
| 2019 |
$1 |
| 2018 |
$2 |
| 2017 |
$1 |
| 2016 |
$-3 |
| 2015 |
$5 |
| 2014 |
$-1 |
| 2013 |
$12 |
| 2012 |
$-1 |
| 2011 |
$-1 |
| 2010 |
$0 |
| 2009 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.001B |
$0.000B |
|
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
|
